Eagle Pharmaceuticals CEO Scott Tarriff's 2019 pay falls 30% to $7.9M
Eagle Pharmaceuticals reports 2019 executive compensation
By ExecPay News
Published: April 29, 2020
Eagle Pharmaceuticals reported fiscal year 2019 executive compensation information on April 29, 2020.
In 2019, four executives at Eagle Pharmaceuticals received on average a compensation package of $4.1M, a 6% decrease compared to previous year.
Average pay of disclosed executives at Eagle Pharmaceuticals
Scott Tarriff, Chief Executive Officer, received $7.9M in total, which decreased by 30% compared to 2018. 37% of Tarriff's compensation, or $3M, was in option awards. Tarriff also received $1.5M in non-equity incentive plan, $769K in salary, $2.6M in stock awards, as well as $21K in other compensation.
For fiscal year 2019, the median employee pay was $245,751 at Eagle Pharmaceuticals. Therefore, the ratio of Scott Tarriff's pay to the median employee pay was 32 to one.
David Pernock, Chief Operating Officer, received a compensation package of $3.2M, which decreased by 14% compared to previous year. 32% of the compensation package, or $1M, was in option awards.
Pete A. Meyers, Chief Financial Officer, earned $2.7M in 2019, which is about the same as previous year.
Adrian J. Hepner, Chief Medical Officer, received $2.7M in 2019, which decreases by 15% compared to 2018.
Related executives
You may also like
Source: SEC filing on April 29, 2020.